Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.65% |
| 2 | Technology | 14.28% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Acadia Realty Trust
AKR
$2.89B
| $7.65M | 0.09% |
617,191
+451,061
| +272% | +$10.2M |
|
|
AAT
302
American Assets Trust
AAT
$1.4B
| $7.61M | 0.09% |
304,296
+53,530
| +21% | +$2.16M |
|
303
NCR Voyix
VYX
$1.09B
| $7.58M | 0.09% |
697,894
-214,445
| -24% | -$3.68M |
|
304
Sabra Healthcare REIT
SBRA
$5.21B
| $7.56M | 0.09% |
691,929
-29,255
| -4% | -$539K |
|
305
PUT
iShares MSCI Turkey ETF
TUR
$228M
| $7.52M | 0.09% |
+400,000
| New | +$10.1M |
|
306
Visteon
VC
$2.83B
| $7.5M | 0.09% |
+156,290
| New | +$11.3M |
|
307
MarketAxess Holdings
MKTX
$5.71B
| $7.47M | 0.09% |
+22,469
| New | +$7.83M |
|
|
MNTV
308
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $7.45M | 0.09% |
551,305
-156,674
| -22% | -$2.69M |
|
309
ICU Medical
ICUI
$4.57B
| $7.41M | 0.09% |
36,735
-74,014
| -67% | -$14.2M |
|
|
LSXMA
310
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $7.39M | 0.09% |
322,586
+52,717
| +20% | +$1.67M |
|
311
RB Global
RBA
$16.1B
| $7.36M | 0.09% |
215,186
-189,633
| -47% | -$7.58M |
|
|
INFO
312
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $7.33M | 0.09% |
+122,133
| New | +$8.79M |
|
|
TWOU
313
DELISTED
2U Inc
TWOU
| $7.28M | 0.09% |
+11,437
| New | +$7.73M |
|
314
Brighthouse Financial
BHF
$3.01B
| $7.27M | 0.09% |
+300,966
| New | +$10.6M |
|
|
NSTG
315
DELISTED
NanoString Technologies, Inc.
NSTG
| $7.25M | 0.09% |
301,579
+91,238
| +43% | +$2.64M |
|
316
Exelixis
EXEL
$13.4B
| $7.21M | 0.09% |
418,533
-74,985
| -15% | -$1.37M |
|
317
PUT
TSMC
TSM
$2.17T
| $7.17M | 0.09% |
+150,000
| New | +$8.2M |
|
318
Seagate
STX
$193B
| $7.14M | 0.08% |
+146,275
| New | +$7.81M |
|
319
CME Group
CME
$98.9B
| $7.13M | 0.08% |
41,207
| – | – |
|
320
Centene
CNC
$32.1B
| $7.05M | 0.08% |
118,713
-25,130
| -17% | -$1.52M |
|
321
Gartner
IT
$12.4B
| $7.04M | 0.08% |
+70,653
| New | +$9.68M |
|
322
Envista
NVST
$4.37B
| $7.01M | 0.08% |
469,170
-1,742,305
| -79% | -$44.6M |
|
|
WMGI
323
DELISTED
Wright Medical Group Inc
WMGI
| $6.99M | 0.08% |
243,870
-624,779
| -72% | -$18.5M |
|
324
STAG Industrial
STAG
$7.07B
| $6.97M | 0.08% |
309,348
-714,105
| -70% | -$20.8M |
|
325
PUT
Danaher
DHR
$154B
| $6.92M | 0.08% |
+56,400
| New | +$7.6M |
|
Similar funds
Dmitry Balyasny's Q1 2020 Portfolio in Review
As of Q1 2020, Dmitry Balyasny held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
Against the trend, Dmitry Balyasny opened a new position in Lowe's Companies worth $86M.
- Dmitry Balyasny's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Dmitry Balyasny added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Dmitry Balyasny's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Dmitry Balyasny fully exited American International in Q1 2020, selling an estimated $193M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Dmitry Balyasny opened 583 new positions and closed 598 in Q1 2020.
- Dmitry Balyasny's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.